Skip to main content

Peer Review reports

From: BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma

Original Submission
10 Mar 2023 Submitted Original manuscript
30 May 2023 Reviewed Reviewer Report
8 Jul 2023 Reviewed Reviewer Report
21 Aug 2023 Author responded Author comments - Qirong Hao
Resubmission - Version 2
21 Aug 2023 Submitted Manuscript version 2
6 Sep 2023 Author responded Author comments - Qirong Hao
Resubmission - Version 3
6 Sep 2023 Submitted Manuscript version 3
19 Sep 2023 Author responded Author comments - Qirong Hao
Resubmission - Version 4
19 Sep 2023 Submitted Manuscript version 4
25 Sep 2023 Author responded Author comments - Qirong Hao
Resubmission - Version 5
25 Sep 2023 Submitted Manuscript version 5
27 Sep 2023 Author responded Author comments - Qirong Hao
Resubmission - Version 6
27 Sep 2023 Submitted Manuscript version 6
9 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 Oct 2023 Editorially accepted
18 Oct 2023 Article published 10.1186/s12885-023-11515-9

You can find further information about peer review here.

Back to article page